These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6408547)

  • 1. Mitomycin C in patients with metastatic breast cancer refractory to hormone therapy and chemotherapy.
    Lopez M; Papaldo P; Di Lauro L; Barduagni M; Perno CF; Barduagni A
    Oncology; 1983; 40(4):244-7. PubMed ID: 6408547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin C in metastatic breast cancer resistant to hormone therapy and conventional chemotherapy.
    De Lena M; Jirillo A; Brambilla C; Villa S
    Tumori; 1980 Aug; 66(4):481-87. PubMed ID: 7414712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
    Denefrio JM; East DR; Troner MB; Vogel CL
    Cancer Treat Rep; 1978 Dec; 62(12):2113-5. PubMed ID: 751719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin].
    Toda K; Asaishi K; Okazaki A; Okazaki Y; Okazaki M; Ebata T; Totsuka M; Hayasaka H; Sato N; Narimatsu E
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2298-304. PubMed ID: 2934023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
    DiBella NJ; Garfield D; Fink K; Anderson P; Speer J; Murphy J
    Oncology; 1984; 41(1):1-3. PubMed ID: 6422372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil and mitomycin C in advanced breast cancer.
    Aspegren K; Landberg T
    Radiother Oncol; 1986 Jun; 6(2):121-6. PubMed ID: 3090650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
    Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of combined 5-fluorouracil and mitomycin C in advanced breast cancer.
    Mattsson W; von Eyben F; Hallsten L; Bjelkengren G
    Cancer; 1982 Jan; 49(2):217-20. PubMed ID: 6797721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective low-dose mitomycin regimen for hormonal- and chemotherapy-refractory patients with metastatic breast cancer.
    Creech RH; Catalano RB; Shah MK; Dayal H
    Cancer; 1983 Mar; 51(6):1034-40. PubMed ID: 6821868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
    Konits PH; Aisner J; van Echo DA; Lichtenfeld K; Wiernik PH
    Cancer; 1981 Sep; 48(6):1295-8. PubMed ID: 6791808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy.
    Pasterz RB; Buzdar AU; Hortobagyi GN; Blumenschein GR
    Cancer; 1985 Nov; 56(10):2381-4. PubMed ID: 4042070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of hexamethylmelamine, cis-diamminedichloroplatinum, and mitomycin-C in advanced breast cancer. A pilot study of the Southeastern Cancer Study Group.
    Lawson D; Moore M; Smalley R
    Cancer Clin Trials; 1980; 3(4):293-6. PubMed ID: 6775826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies.
    Hum GJ; Bogdon DL; Bateman JR
    Oncology; 1974; 30(3):236-43. PubMed ID: 4459738
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.
    Nabholtz JM; Senn HJ; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Molino A; Nortier JW; Richel DJ; Nagykalnai T; Siedlecki P; Wilking N; Genot JY; Hupperets PS; Pannuti F; Skarlos D; Tomiak EM; Murawsky M; Alakl M; Aapro M
    J Clin Oncol; 1999 May; 17(5):1413-24. PubMed ID: 10334526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin-C plus metronidazole in advanced carcinoma of the breast.
    Stewart DJ; Maroun JA; Lefebvre B; Heringer R; Crook AF
    Breast Cancer Res Treat; 1985; 5(2):189-94. PubMed ID: 3926028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.
    Ingle JN; Mailliard JA; Schaid DJ; Krook JE; Gerstner JB; Pfeifle DM; Marschke RF; Long HJ; McCormack GW; Foley JF
    Am J Clin Oncol; 1989 Dec; 12(6):474-80. PubMed ID: 2686393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.
    Legha SS; Buzdar AU; Hortobagyi GN; DiStefano A; Wiseman CL; Yap HY; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979; 63(11-12):2053-6. PubMed ID: 118805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.